Skip to main content
Premium Trial:

Request an Annual Quote

Stratagene Settles PCR Litigation with Takara Bio

NEW YORK, May 12 (GenomeWeb News) - Stratagene and Takara Bio have settled a patent disputes related to PCR enzyme blends, Stratagene said today in an 8-K filing with the US Securities and exchange Commission.

 

As a result of the settlement, "all pending litigation over patent issues in the US District Court for the District of Maryland and in the US Patent & Trademark Office will be dismissed," Stratagene said. "Potential disputes in the future will be avoided through cross-licenses of the parties' respective patent rights relating to enzyme blends."

    

Stratagene did not disclose the financial details of the settlement, but said that each company "believes the principal, direct financial effect of the settlement will be the avoidance of the costs and risks of continued litigation."

 

The firms have agreed to pay "reasonable" royalties to each other under certain licensed patents, and each company will be free to independently license its patents to third parties.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.